BRGX — BioRegenx Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for BioRegenx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2012 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st
Period Length:	—	—	—	—	—
Source:	PRESS	10-K	10-K	10-K	10-Q
Standards:	—	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.281	0.094	0.024	0.001	0.125
Net Total Accounts Receivable
Net Total Receivables	0.068	0.001	0	—	0.033
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.625	0.095	0.024	0.001	0.941
Net Property, Plant And Equipment	0.239	—	—	—	0.014
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	3.8	0.368	0.128	0.059	1.69
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.36	0.042	0.014	0.065	2.53
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	5.46	0.19	0.212	0.261	2.88
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.65	0.178	-0.084	-0.202	-1.19
Total Liabilities & Shareholders' Equity	3.8	0.368	0.128	0.059	1.69
Total Common Shares Outstanding
Total Preferred Shares Outstanding